BioCentury | May 29, 2019
Preclinical News

May 29 Preclinical Quick Takes: Vor debuts lead stem cell program; plus an inverse Alzheimer's-cancer target, and statins for cognitive defects

...CAR Ts (see "Beyond B Cells" ). Deleting gene linked to Alzheimer's kills HER2+ cancer University of Turku...
...LR11) - Sortilin-related receptor 1 Mary Romeo, Staff Writer Columbia University Massachusetts Institute of Technology PureTech Health plc University of Edinburgh University of Turku Vor...
BioCentury | Mar 8, 2019
Targets & Mechanisms

Flipping the switch in immuno-oncology

...an M1. Based on mechanistic studies in STAB1 conditional knockout mice, a group at the University of Turku...
...Windsor, U.K. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland University of Turku...
...cell activation Allison Johnson, Staff Writer Clevegen (FP-1305) Carisma Therapeutics Inc. Codiak BioSciences Inc. Faron Pharmaceuticals Oy FLX Bio Inc. Macrophage Pharma Ltd. University of Turku Verseau...
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cancer

...et al. Sci. Transl. Med. ; published online July 18, 2018 doi:10.1126/scitranslmed.aaq1093 CONTACT: Jukka Westermarck, University of Turku...
...Case Western Reserve University, Cleveland, Ohio email: gnarla@med.umich.edu Sandi Wong Array BioPharma Inc. Case Western Reserve University Rappta Therapeutics LLC University of Turku K-Ras...
BioCentury | Jan 3, 2017
Distillery Therapeutics

Cancer

...University of Turku, Turku, Finland email: guillaume.jacquemet@utu.fi CONTACT: Johanna Ivaska, same affiliation as above email: Johanna.ivaska@utu.fi Hongjiang Li Creative Commons University of Turku Calcium...
BioCentury | Aug 18, 2016
Distillery Techniques

Techniques: Branched-chain amino acids from gut microbes as markers of insulin resistance

...CONTACT: Søren Brunak, Technical University of Denmark, Kongens Lyngby, Denmark email: soren.brunak@cpr.ku.dk CONTACT: Matej Oresic, University of Turku...
BioCentury | Nov 7, 2013
Distillery Therapeutics

Indication: Cancer

...licensing Khanna, A. et al. Cancer Res.; published Sept. 26, 2013; doi:10.1158/0008-5472.CAN-13-1002 Contact: Jukka Westermarck, University of Turku...
BioCentury | Jan 30, 2012
Company News

Arctic Partners, Opko deal

...of having prostate cancer. Arctic has rights to the biomarkers from Malmo University (Malmo, Sweden), University of Turku...
BioCentury | May 24, 2010
Emerging Company Profile

Alios: One for all

...Founded: 2007 by Lawrence Blatt and Leonid Beigelman University collaborators: The Cleveland Clinic and the University of Turku...
BioCentury | Mar 23, 2009
Clinical News

Food and Drug Administration, National Institutes of Health, University of Turku preclinical data

...Food and Drug Administration , Silver Spring, Md. National Institutes of Health , Bethesda, Md. University of Turku...
BioCentury | Sep 23, 2002
Clinical News

Huvap vapaliximab: Phase I

...Huvap in 36 healthy volunteers. Huvap was developed in collaboration with Cambridge University and the University of Turku...
Items per page:
1 - 10 of 11
BioCentury | May 29, 2019
Preclinical News

May 29 Preclinical Quick Takes: Vor debuts lead stem cell program; plus an inverse Alzheimer's-cancer target, and statins for cognitive defects

...CAR Ts (see "Beyond B Cells" ). Deleting gene linked to Alzheimer's kills HER2+ cancer University of Turku...
...LR11) - Sortilin-related receptor 1 Mary Romeo, Staff Writer Columbia University Massachusetts Institute of Technology PureTech Health plc University of Edinburgh University of Turku Vor...
BioCentury | Mar 8, 2019
Targets & Mechanisms

Flipping the switch in immuno-oncology

...an M1. Based on mechanistic studies in STAB1 conditional knockout mice, a group at the University of Turku...
...Windsor, U.K. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland University of Turku...
...cell activation Allison Johnson, Staff Writer Clevegen (FP-1305) Carisma Therapeutics Inc. Codiak BioSciences Inc. Faron Pharmaceuticals Oy FLX Bio Inc. Macrophage Pharma Ltd. University of Turku Verseau...
BioCentury | Aug 8, 2018
Distillery Therapeutics

Cancer

...et al. Sci. Transl. Med. ; published online July 18, 2018 doi:10.1126/scitranslmed.aaq1093 CONTACT: Jukka Westermarck, University of Turku...
...Case Western Reserve University, Cleveland, Ohio email: gnarla@med.umich.edu Sandi Wong Array BioPharma Inc. Case Western Reserve University Rappta Therapeutics LLC University of Turku K-Ras...
BioCentury | Jan 3, 2017
Distillery Therapeutics

Cancer

...University of Turku, Turku, Finland email: guillaume.jacquemet@utu.fi CONTACT: Johanna Ivaska, same affiliation as above email: Johanna.ivaska@utu.fi Hongjiang Li Creative Commons University of Turku Calcium...
BioCentury | Aug 18, 2016
Distillery Techniques

Techniques: Branched-chain amino acids from gut microbes as markers of insulin resistance

...CONTACT: Søren Brunak, Technical University of Denmark, Kongens Lyngby, Denmark email: soren.brunak@cpr.ku.dk CONTACT: Matej Oresic, University of Turku...
BioCentury | Nov 7, 2013
Distillery Therapeutics

Indication: Cancer

...licensing Khanna, A. et al. Cancer Res.; published Sept. 26, 2013; doi:10.1158/0008-5472.CAN-13-1002 Contact: Jukka Westermarck, University of Turku...
BioCentury | Jan 30, 2012
Company News

Arctic Partners, Opko deal

...of having prostate cancer. Arctic has rights to the biomarkers from Malmo University (Malmo, Sweden), University of Turku...
BioCentury | May 24, 2010
Emerging Company Profile

Alios: One for all

...Founded: 2007 by Lawrence Blatt and Leonid Beigelman University collaborators: The Cleveland Clinic and the University of Turku...
BioCentury | Mar 23, 2009
Clinical News

Food and Drug Administration, National Institutes of Health, University of Turku preclinical data

...Food and Drug Administration , Silver Spring, Md. National Institutes of Health , Bethesda, Md. University of Turku...
BioCentury | Sep 23, 2002
Clinical News

Huvap vapaliximab: Phase I

...Huvap in 36 healthy volunteers. Huvap was developed in collaboration with Cambridge University and the University of Turku...
Items per page:
1 - 10 of 11